RenovoRx, Inc.

RNXT · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$9-$10-$10-$6
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$1$1$0$0
Change in WC$0$1$0-$0
Other Non-Cash-$2-$2$1$1
Operating Cash Flow-$9-$10-$9-$6
Investing Activities
PP&E Inv.-$0$0$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0-$8$0
Inv. Sales/Matur.$0$2$6$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$0$2-$2-$0
Financing Activities
Debt Repay.$0$0$0$2
Stock Issued$15$5$0$15
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$3
Financing Cash Flow$15$5$0$19
Forex Effect$0$0$0$0
Net Chg. in Cash$6-$3-$11$13
Supplemental Information
Beg. Cash$1$4$15$2
End Cash$7$1$4$15
Free Cash Flow-$9-$10-$9-$6
RenovoRx, Inc. (RNXT) Financial Statements & Key Stats | AlphaPilot